Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunotherapeutic HCW9218 augments anti-tumor activity of chemotherapy via NK cell-mediated reduction of therapy-induced senescent cells
Pallavi Chaturvedi, Varghese George, Niraj Shrestha, et al.
Molecular Therapy (2022) Vol. 30, Iss. 3, pp. 1171-1187
Open Access | Times Cited: 19

Showing 19 citing articles:

Research progress of interleukin-15 in cancer immunotherapy
Menghan Cai, Xuan Huang, Xiting Huang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 35
The TGF-β Family in Glioblastoma
Irene Golán‐Cancela, Laia Caja
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 2, pp. 1067-1067
Open Access | Times Cited: 13
Cellular senescence and metabolic reprogramming: Unraveling the intricate crosstalk in the immunosuppressive tumor microenvironment
Fusheng Zhang, Junchen Guo, Shengmiao Yu, et al.
Cancer Communications (2024) Vol. 44, Iss. 9, pp. 929-966
Open Access | Times Cited: 12
Immunotherapeutic approach to reduce senescent cells and alleviate senescence‐associated secretory phenotype in mice
Niraj Shrestha, Pallavi Chaturvedi, Xiaoyun Zhu, et al.
Aging Cell (2023) Vol. 22, Iss. 5
Open Access | Times Cited: 17
Targeted Therapy for Highly Desmoplastic and Immunosuppressive Tumor Microenvironment of Pancreatic Ductal Adenocarcinoma
Olamide Tosin Olaoba, Ming Yang, Temitope Isaac Adelusi, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1470-1470
Open Access | Times Cited: 5
Potentiation of natural killer cells to overcome cancer resistance to NK cell-based therapy and to enhance antibody-based immunotherapy
Massimo Claudio Fantini, Philip M. Arlen, Kwong Y. Tsang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
The Potential of Senescence as a Target for Developing Anticancer Therapy
Hyein Jo, Kyeonghee Shim, Dooil Jeoung
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3436-3436
Open Access | Times Cited: 10
The Cross Talk between Cellular Senescence and Melanoma: From Molecular Pathogenesis to Target Therapies
Jiahua Liu, Runzi Zheng, Yanghuan Zhang, et al.
Cancers (2023) Vol. 15, Iss. 9, pp. 2640-2640
Open Access | Times Cited: 10
Stimulating the Antitumor Immune Response Using Immunocytokines: A Preclinical and Clinical Overview
Bart Boersma, Hélène Poinot, Aurélien Pommier
Pharmaceutics (2024) Vol. 16, Iss. 8, pp. 974-974
Open Access | Times Cited: 3
NeRD: a multichannel neural network to predict cellular response of drugs by integrating multidimensional data
Xiaoxiao Cheng, Chong Dai, Yuqi Wen, et al.
BMC Medicine (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Immunomodulation: A new approach to cancer cachexia, potentially suitable for aging
Fabio Penna, Giacomo Rubini, Paola Costelli
Molecular Aspects of Medicine (2024) Vol. 100, pp. 101318-101318
Open Access | Times Cited: 2
A novel interleukin-2-based fusion molecule, HCW9302, differentially promotes regulatory T cell expansion to treat atherosclerosis in mice
Xiaoyun Zhu, Qiongzhen Li, Varghese George, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 6
Pasteurized Akkermansia muciniphila improves immunity and relieves other toxic effects in 5-fluorouracil treated BALB/c mice
Yue Teng, Dongyun Zhao, Chunhong Yan, et al.
Food Bioscience (2024) Vol. 59, pp. 103918-103918
Closed Access | Times Cited: 1
Impact and potential value of immunosenescence on solid gastrointestinal tumors
Tianshuai Zhang, Rongbo Wen, Hao Fan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Novel insights into immune cells modulation of tumor resistance
Yiqing Zhou, Chuhan Na, Zhigang Li
Critical Reviews in Oncology/Hematology (2024) Vol. 202, pp. 104457-104457
Closed Access | Times Cited: 1
Identification of Immune-Related Subtypes and Construction of a Novel Prognostic Model for Bladder Urothelial Cancer
Jiange Zhang, Caisheng Huang, Rirong Yang, et al.
Biomolecules (2022) Vol. 12, Iss. 11, pp. 1670-1670
Open Access | Times Cited: 6
TGF-β in tumor microenvironment, metabolism, and immunotherapy
Haotian Bai, Yisong Y. Wan
Elsevier eBooks (2024), pp. 53-93
Closed Access
724 A phase I study of HCW9218, a bifunctional TGF-β Antagonist/IL-15 protein complex, in advanced solid tumors
Melissa A. Geller, Manish R. Patel, Hing C. Wong, et al.
Regular and Young Investigator Award Abstracts (2022), pp. A757-A757
Open Access | Times Cited: 1
767 Pre-clinical and first-in-human studies of HCW9218, a bifunctional TGF-β antagonist/IL-15 protein complex, in advanced solid tumors
Melissa A. Geller, Manish R. Patel, Hing C. Wong, et al.
Regular and Young Investigator Award Abstracts (2023), pp. A862-A862
Open Access
Page 1

Scroll to top